-
-
Overview
-
Product performance
· Overcome the world's difficult problem of γδ-T cell cryopreservation that cannot be solved by traditional cryopreservation fluids, and achieve a breakthrough from 0 to 1.
· The effectiveness of cryopreservation has been greatly improved. 24 hours after cryopreservation and thawing, the viability of γδ-T cells has increased by 51% compared with a certain brand, overcoming the problem that the number of γδ-T cells after cryopreservation cannot meet the treatment needs.
· The tumor killing rate reached 84.3% 24 hours after cryopreservation and thawing, which is close to fresh tissue cells, has better tumor killing effect, reduces the R&D and production costs of enterprises, improves R&D and production efficiency, and lays the foundation for promoting cell drugs to become "shelf drugs".
Features
· Developed based on controlled ice storage technology
· Double cryoprotectant, containing self-developed controlled ice protection agent + 10% USP grade DMSO
· Cell viability>90%
· Serum-free, protein-free, animal-free
· Full pharmacopoeia ingredients, clear components, pharmaceutical-grade raw materials
· Sterile, low endotoxin, <0.125 EU/mL
· High safety, high recovery rate, ultra-high ease of use
· Support ultra-high density cryopreservation, 1×10^6~1×10^8 cells/mL
· GMP grade
· Ready-to-use, can be stored and transported over long distances at 2~8°C
· Support direct freezing, no need for programmed cooling box (Short-term storage: -80°C freezer. For long-term storage, transfer to -196°C liquid nitrogen after 12 hours.)Please contact us at for specific academic pricing.
More Details
-
- Properties
- Applications
-
Overview